Walgreens adds weight management visits to its virtual care service

Walgreens Virtual Healthcare started offering weight management services on Feb. 26, 2026, adding on-demand follow-up visits by chat or video for patients who need medication adjustments or help managing side effects ^[1]. The company described the addition as part of a wider push by retail pharmacies into GLP-1 care ^[1].

The follow-up visits are the centerpiece of the offering. Patients can connect with a clinician by chat or video when a weight-loss medication needs adjusting or when side effects need to be handled, according to the announcement ^[1]. The visits are delivered through Walgreens Virtual Healthcare, the company's existing virtual care service ^[1].

The announcement left several practical questions unanswered ^[1]. Walgreens did not disclose the price of a weight management visit, whether insurance is accepted, or which states the service is available in ^[1]. It also did not say whether the virtual clinicians can write new prescriptions for GLP-1 drugs such as semaglutide (sold as Ozempic, Wegovy and Rybelsus) or tirzepatide (sold as Mounjaro and Zepbound), or whether the service is limited to patients who already have a prescription from another provider ^[1]. The credentials of the clinicians staffing the service and how quickly a patient could be seen were not described ^[1].

Why it matters for patients

Medication adjustments and side effect management are the two reasons the service is built around, and they are the reasons patients most often need to reach a prescriber between scheduled visits ^[1]. A chat or video option aimed at exactly those tasks could give patients a second route to a clinician without an in-person appointment, at least for patients who already have a prescription and a plan in place.

What the visit can actually change is less clear. The announcement describes medication adjustments and side effect management ^[1], but does not say whether a clinician can send a new prescription to a pharmacy, change a dose originally written by another prescriber, or order lab work. A visit that can answer questions but not alter a prescription is a different product than one that can.

Cost is the other open item. Whether a patient pays a flat cash price or a copay, and whether the service takes insurance, has not been disclosed ^[1], so it is not possible to compare the new service with a primary care visit, an existing telehealth subscription, or a visit with the prescriber who started the medication. For patients whose main concern is staying in touch with someone who can respond to a dose change or a rough week of side effects, the unanswered questions about coverage and prescription authority are the ones that would decide whether the service fits their situation.

Walgreens is not alone in this space — the company placed the launch in the context of retail pharmacies expanding into GLP-1 care ^[1] — but the announcement did not name competitors or compare the service with any other program ^[1].

What happens next

The announcement did not include a date for broader expansion, a pricing schedule, or a list of participating states ^[1]. Until those details are published, the only firm date attached to the service is the Feb. 26, 2026 launch ^[1]. Whether Walgreens adds prescribing, lab ordering, or insurance billing later has not been reported ^[1].